Connection
Erin Schenk to Pyrazines
This is a "connection" page, showing publications Erin Schenk has written about Pyrazines.
|
|
Connection Strength |
|
 |
|
 |
|
0.097 |
|
|
|
-
Schenk E, Hendrickson AE, Northfelt D, Toft DO, Ames MM, Menefee M, Satele D, Qin R, Erlichman C. Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies. Invest New Drugs. 2013 Oct; 31(5):1251-6.
Score: 0.097